期刊文献+

冠心病冠脉支架术后患者再狭窄发生的危险因素 被引量:3

The Risk Factors for Coronary Heart Disease in Patients With Coronary Stent Restenosis
下载PDF
导出
摘要 目的探究冠心病冠脉支架术后患者再狭窄发生的危险因素。方法选取我院2014年8月-2015年8月成功给予冠脉支架术治疗的63例冠心病患者进行回顾性分析,根据是否再狭窄分为对照组(19例)与研究组(44例),采用单因素与Logistic多因素分析两组患者的临床资料、生化指标等。结果两组患者在糖尿病、高血压、吸烟、血清总胆红素、血尿酸、植入支架长度及直径因素对比均显示高度差异(P〈0.05)。结论冠心病患者行冠脉支架术时,临床应仔细考虑植入支架的直径与长度,且于术后密切观察患者的血清生化指标检测情况,并嘱其积极治疗糖尿病及戒烟。 Objective To explore coronary stent restenosis in patients of risk factors.Methods Selected 63 cases of coronary heart disease in patients with successful coronary stenting from August 2014 to August 2015 in our hospital,which were retrospectively analyzed according to whether restenosis divided into the control group(19 cases) and the study group(44 cases),used univariate and multivariate analysis Logistic two clinical data,biochemical indicators.Results The two groups in diabetes,hypertension,smoking,serum total bilirubin,uric acid,stent length and diameter of the factors comparison showed the difference in height(P〈0.05).Conclusion When coronary stenting in patients with coronary heart disease,clinical response implanted stent diameter and length of careful consideration and in serum biochemical parameters after close observation of the patient's condition is detected,and has asked its aggressive treatment of diabetes and smoking.
作者 刘泉
出处 《中国继续医学教育》 2016年第2期75-76,共2页 China Continuing Medical Education
关键词 冠心病 冠脉支架术 再狭窄 危险因素 Coronary disease Coronary stenting Restenosis Hazards
  • 相关文献

参考文献7

二级参考文献56

  • 1王哲颖,刘同库.雷帕霉素洗脱支架治疗无保护冠状动脉左主干严重狭窄性病变的安全性和远期效果研究[J].中国全科医学,2013,16(27):3192-3195. 被引量:10
  • 2杨卓璇,黄淑田,仝珊.代谢综合征合并冠心病患者血清总胆红素水平与冠脉病变程度的关联研究[J].中国心血管病研究,2007,5(8):580-582. 被引量:12
  • 3Sigwartu H, Puel J, Mirkovitch V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty [ J ]. N Engl J Med,1987,316(12) :701-706.
  • 4Kent K, Mullin SM, Passamani ER. Proceedings of theNational Heart, Lung, and Blood Institute Workshop on the outcome of percutaneous transluminal angioplasty [ J ]. J Am Cardiol, 1984,53 (12) : 1-14.
  • 5Cola C, Brugaletta S, Martin Yuste V, et al. Diabetes mellitus: a prothrombotic state Implications for outcomes after coronary revas-cularization[J]. Vascular Heal Risk Manag, 2009,5 ( 1 ) : 101- 119.
  • 6van Bergen PF, Deekem IW, Jonker J J, et al. Efficacy of long term anticoagulant treatment in subgroups of patients after myocardial infarotion[J]. Br Heart J, 1995,74(2) :117-121.
  • 7Bulmer AC, B1 anchfield JT, Toth I, et al. Improved resistance to serum oxidation in Gilbe syndrome : a mechanism for cardiovascular protection[J]. Atherosclerosis, 2008, 199(2) : 390-396.
  • 8Tanaka M, Fukui M, Tomiyasu K, et al. Low serum bilirubin concentration is associated with coronary artery calcification (CAC) [J]. Atherosclerosis, 2009,206( 1 ) :287-291.
  • 9Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups [J]. N Engl J Med, 2008,358 ( 13 ) : 1336-1345.
  • 10Tamhane U, Meier P, Cheteuti S, et al. Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials. Euro Intervention,2009,5 : 384-393.

共引文献90

同被引文献18

引证文献3

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部